Medical News

RSS

Apotex passes Bill C-393 to fix Canada's Access to Medicines Regime

Apotex Inc, Canada's largest pharmaceutical company, today underscored the need for Members of Parliament to fix Canada's Access to Medicines Regime by passing Bill C-393 when it comes up for final vote tomorrow, March 9, 2011.

9 Mar 2011

Health law policy disputes central to congressional spending fight

As lawmakers tussle over how much spending should be cut in this year's budget, these key policy questions related to the health law and other regulatory issues are a flashpoint. In addition, House Republicans are stepping up their strategies to defund the overhaul.

9 Mar 2011

'Cross-talk' between two major biological pathways may hold a clue for chronic pain treatment

Researchers at the University of California, Davis have discovered a "cross-talk" between two major biological pathways that involve pain-research that may pave the way to new approaches to understanding and controlling chronic pain.

9 Mar 2011

Multiple target therapy may treat HER2-positive breast cancers

Combining targeted therapies might be required for maximum anti-tumor activity when treating HER2-positive breast cancers, according to two new studies by Vanderbilt-Ingram Cancer Center investigators.

9 Mar 2011

GRACE model improves health and reduces Medicare costs in high risk seniors

The March 2011 issue of the journal Heath Affairs highlights an evidence-based model of geriatric care management developed, implemented and tested by researchers and clinicians from Indiana University, the Regenstrief Institute and Wishard Health Services.

9 Mar 2011

Postdoctoral research fellows receive Pancan- AACR Pathway to Leadership Grants

The Pancreatic Cancer Action Network and the American Association for Cancer Research have awarded Jennifer M. Bailey, Ph.D., and E. Scott Seeley, M.D., Ph.D., the 2011 Pancreatic Cancer Action Network - AACR Pathway to Leadership Grants.

9 Mar 2011

Survey: Most HIV-positive patients die of cancer

Most HIV-positive patients die of cancer. In the latest issue of Deutsches Ärzteblatt International, Manfred Hensel's research group presents epidemiological data.

9 Mar 2011

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

9 Mar 2011

Senate 'Gang of six' launches public campaign for deficit reduction

Their effort focuses on educating the public about the importance of overhauling Medicare and other entitlement programs if the national debt is to be tamed.

9 Mar 2011

FDA approves Ipsen's application for Extended Dosing Interval of Somatuline Depot for acromegaly

Ipsen announced today that the Food and Drug Administration (FDA) has approved Ipsen's Prior Approval Supplement application for the Extended Dosing Interval of Somatuline® Depot for patients suffering from acromegaly.

9 Mar 2011

Sanfilippo syndrome compromises blood-brain barrier, leads to brain damage

A study into the effects of Sanfilippo Syndrome type B (MPS III B) has found that the barrier responsible for protecting the brain from the entry of harmful blood-borne substances is structurally and functionally damaged by the devastating disease. University of South Florida researchers identified damage in specific brain structures involved in the pathology of MPS III B, one of four Sanfilippo syndromes, all of which are inherited diseases of metabolism.

9 Mar 2011

Parkinson's disease medication turns on critical gene, protects brain cells

In a major breakthrough in the battle against Parkinson's disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans.

9 Mar 2011

Heated debate surrounds Physician Compare database

Physician Compare might not seem like the kind of tool that would spark a divisive policy debate. It's a website, recently launched by Medicare officials, that allows patients to find a cardiologist, a pediatrician, or other Medicare provider in their zip code.

9 Mar 2011

Therapeutic potential of iPS cells may be limited by reprogramming errors and genomic instability

In the past few months, a slew of papers have indicated that the therapeutic potential of a promising type of stem cell, called induced pluripotent stem (iPS) cells, might be limited by reprogramming errors and genomic instability. iPS cells are engineered by reprogramming fully differentiated adult cells, often skin cells, back to a primitive, embryonic-like state.

9 Mar 2011

Autoimmune response mediated by T lymphocytes may play vital role in pathogenesis of biliary atresia

Biliary atresia (BA) is an inflammatory obliterative cholangiopathy with unknown etiology, leading to progressive fibrosis and cirrhosis. Microarray technology, emerged as an indispensable research tool for gene expression profiling, has been used to study the mechanism underlying BA, and allows the simultaneous analysis of thousands of transcripts within a single experiment.

9 Mar 2011

HHS unveils format for consumer notices of insurance rate increases

Meanwhile, in other policy news related to the health law, Stateline examines how, for some states, waivers really are a big deal.

9 Mar 2011

Colonoscopy can serve as effective tool to reduce colorectal cancer death

In recognition of National Colorectal Cancer Awareness Month during March, GIE: Gastrointestinal Endoscopy has published a special issue for March on colonoscopy and colorectal cancer.

9 Mar 2011

Karolinska Institutet, LUMC coordinate largest European program on RA

Karolinska Institutet in Sweden and Leiden University Medical Center (LUMC) in the Netherlands will coordinate the largest European program so far, aimed at developing new therapies against Rheumatoid Arthritis (RA). The program, named Be The Cure (BTCure), is funded for the next 5 years by the Innovative Medicines Initiative (IMI), and will bring together academic rheumatology research and research in pharmaceutical companies in Europe.

9 Mar 2011

Pulse Health's Revelar device helps minimize free radical damage

Pulse Health announces Revelar the first non-invasive device to help healthcare professionals and their patients measure aldehydes and help minimize free radical damage. Revelar is breakthrough breath technology that accurately detects and measures the presence of aldehydes, which are indicators of free radical damage in the body.

9 Mar 2011

LRI announces 12 new research grants to drive innovation in lupus

The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.

9 Mar 2011